ROSE LifeScience receives Research Licence from Health Canada
02 August 2024 - 3:13AM
ROSE LifeScience Inc. (“ROSE”), a leading Quebec-based cannabis
producer, distributor, and marketer, majority-owned by Village
Farms International (Nasdaq: VFF), announced today that it has
received a Cannabis Research Licence from Health Canada under the
Cannabis Act. This authorization enables ROSE to focus on cannabis
product innovations and developments.
For sanctioned cannabis producers, a Research
Licence authorizing non-therapeutic research on cannabis permits
in-house sensory and other consumer preference testing on many
forms and derivatives of cannabis, with the intention of developing
and refining products and technologies.“This licence increases our
capacity to drive innovation, from fine-tuning strain profiles to
identifying and validating value-added technologies,” said Davide
Zaffino, President and CEO, ROSE. “With the freedom to test
products internally, our ability to serve the customer and consumer
improves. This means consumers across Canada can receive products
that are more advanced and more understood in a much shorter
timeline. This benefits everyone in our industry.”About ROSE
LifeScience Inc.ROSE LifeScience is committed to ensuring that
consumers benefit from the responsible production, sale, and
consumption of cannabis in Québec and across Canada. From
cannabis cultivation to marketing, commercialization, and
logistics, the Huntingdon, QC company plays a key role in
the Québec market. In addition to its own products and expertise,
ROSE provides specialized industry services to selected producers
to encourage a diversified offering in the Québec and Canadian
markets. Rose LifeScience is majority owned by Village Farms
International (Nasdaq: VFF) with the balance owned and operated by
its Québec-based founders. For more information,
visit roselifescience.ca.
About Village Farms InternationalVillage Farms leverages decades
of experience as a large-scale, Controlled Environment
Agriculture-based, vertically integrated supplier for high-value,
high-growth plant-based Consumer Packaged Goods opportunities, with
a strong foundation as a leading fresh produce supplier to grocery
and large-format retailers throughout the U.S. and Canada, and new
high-growth opportunities in the cannabis and CBD categories in
North America, the Netherlands and selected markets
internationally.
The Company's wholly owned Canadian subsidiary, Pure Sunfarms,
is one of the single largest cannabis operations in the world, the
lowest-cost greenhouse producer and one of Canada’s best-selling
brands. The Company also owns 80% of Québec-based, Rose
LifeScience, a leading third-party cannabis products
commercialization expert in the Province of Québec. Village Farms
ranks as the #2 producer nationally in Canada.
In the U.S., wholly owned Balanced Health Botanicals is one of
the leading CBD brands and e-commerce platforms in the country.
Subject to compliance with all applicable US federal and state laws
and stock exchange rules, Village Farms plans to enter the US
high-THC cannabis market via multiple strategies, leveraging one of
the largest greenhouse operations in the country (more than 5.5
million square feet in West Texas), as well as the operational and
product expertise gained through Pure Sunfarms' cannabis success in
Canada.
Internationally, Village Farms is targeting selected, nascent,
legal cannabis and CBD opportunities with significant medium and
long-term potential, with an initial focus on the Asia-Pacific
region and Europe. In the Netherlands, it is the only North
American producer to hold one of ten cannabis licenses in this
limited license country.
For media inquiries, please contact: Valentine VaillantChief
Commercial Officer
valentine.vaillant@roselifescience.ca438 989-6654
Village Farms (NASDAQ:VFF)
Historical Stock Chart
From Sep 2024 to Oct 2024
Village Farms (NASDAQ:VFF)
Historical Stock Chart
From Oct 2023 to Oct 2024